Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728068 | SCV000855594 | benign | not specified | 2017-07-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001541041 | SCV001758991 | benign | not provided | 2019-01-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001541041 | SCV002446486 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001541041 | SCV002496742 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | TRIOBP: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV001541041 | SCV005206421 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003918184 | SCV004736834 | benign | TRIOBP-related disorder | 2020-03-16 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |